2-Chloro-4-nitropyridine

Catalog No.: 
ACNZPV256
CAS No.: 
23056-36-2
Molecular Formula: 
C5H3ClN2O2
Molecular Weight: 
158.54
2-Chloro-4-nitropyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$71.00In stockInquiry
500g98%$355.00In stockInquiry
1000g98%$561.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-4-nitropyridine
IUPAC Name2-chloro-4-nitropyridine
MDL No.MFCD00661454
Molecular FormulaC5H3ClN2O2
Molecular Weight158.54
SMILESClC1=NC=CC(=C1)[N+](=O)[O-]
InChI KeyLIEPVGBDUYKPLC-UHFFFAOYSA-N
SynonymBCP26367 | W-201963 | AJ-333/25006257 | Pyridine, 2-chloro-4-nitro- | 2-chloro-4nitropyridine | 2-Chloro-4-nitropyridine | 2-chloro-4-nitro-pyridine | 2chloro-4-nitropyridine | AKOS000320214 | SCHEMBL190411 | C2283 | STL227623 | LIEPVGBDUYKPLC-UHFFFAOYSA-
CAS No.23056-36-2
PubChem CID735152

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302+H312+H332-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312+P330-P302+P352+P312-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACNZPV256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLPDI531 route compound structure diagram
    ACLPDI5311360438-45-4
  2. Then
  3. ACNZPV256 route product structure diagram
    ACNZPV25623056-36-2In Stock
Inquiry

2. ACNZPV256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNZPV256 route product structure diagram
    ACNZPV25623056-36-2In Stock
Inquiry

3. ACNZPV256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNZPV256 route product structure diagram
    ACNZPV25623056-36-2In Stock
Inquiry

Comments (0)